Capecitabine in Combination with Standard (Neo)Adjuvant Regimens in Early Breast Cancer: Survival Outcome from a Meta-Analysis of Randomized Controlled Trials

Capecitabine has been investigated in early breast cancer in several studies, but it was undefined that whether it could improve survival. To investigate whether the addition of capecitabine affected survival in patients with early breast cancer, a meta-analysis was conducted and overall survival (O...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ze-Chun, Xu, Qi-Ni, Lin, Sui-Ling, Li, Xu-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065157/
https://www.ncbi.nlm.nih.gov/pubmed/27741288
http://dx.doi.org/10.1371/journal.pone.0164663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065157/
https://www.ncbi.nlm.nih.gov/pubmed/27741288
http://dx.doi.org/10.1371/journal.pone.0164663

Ejemplares similares